139 related articles for article (PubMed ID: 20586873)
1. Serological analysis of Helicobacter hepaticus infection in patients with biliary and pancreatic diseases.
Shimoyama T; Takahashi R; Abe D; Mizuki I; Endo T; Fukuda S
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S86-9. PubMed ID: 20586873
[TBL] [Abstract][Full Text] [Related]
2. Serum antibodies to enterohepatic Helicobacter spp. in patients with chronic liver diseases and in a population with high prevalence of H. pylori infection.
Vorobjova T; Nilsson I; Terjajev S; Granholm M; Lyyra M; Porkka T; Prükk T; Salupere R; Maaroos HI; Wadström T; Uibo R
Dig Liver Dis; 2006 Mar; 38(3):171-6. PubMed ID: 16464652
[TBL] [Abstract][Full Text] [Related]
3. Characterization and application of a new monoclonal antibody with high specificity for Helicobacter hepaticus.
Fukuda Y; Shimoyama T; Ohmura T; Sano Y; Nakabayashi N; Takahashi R; Fujioka T; Mitchell HM; Shimoyama T
Helicobacter; 2009 Feb; 14(1):66-71. PubMed ID: 19191899
[TBL] [Abstract][Full Text] [Related]
4. Changes in the prevalence of Helicobacter pylori infection and gastrointestinal diseases in the past 17 years.
Nakajima S; Nishiyama Y; Yamaoka M; Yasuoka T; Cho E
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S99-S110. PubMed ID: 20586876
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
6. Detection of Helicobacter hepaticus in human bile samples of patients with biliary disease.
Hamada T; Yokota K; Ayada K; Hirai K; Kamada T; Haruma K; Chayama K; Oguma K
Helicobacter; 2009 Dec; 14(6):545-51. PubMed ID: 19889072
[TBL] [Abstract][Full Text] [Related]
7. Serological response to specific Helicobacter pylori antigens: antibody against CagA antigen is not predictive of gastric cancer in a developing country.
Mitchell HM; Hazell SL; Li YY; Hu PJ
Am J Gastroenterol; 1996 Sep; 91(9):1785-8. PubMed ID: 8792699
[TBL] [Abstract][Full Text] [Related]
8. Infection with Helicobacter bilis but not Helicobacter hepaticus was Associated with Extrahepatic Cholangiocarcinoma.
Segura-López FK; Avilés-Jiménez F; Güitrón-Cantú A; Valdéz-Salazar HA; León-Carballo S; Guerrero-Pérez L; Fox JG; Torres J
Helicobacter; 2015 Jun; 20(3):223-30. PubMed ID: 25582431
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type.
Delchier JC; Lamarque D; Levy M; Tkoub EM; Copie-Bergman C; Deforges L; Chaumette MT; Haioun C
Am J Gastroenterol; 2001 Aug; 96(8):2324-8. PubMed ID: 11513169
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori: seroprevalence and colorectal cancer.
Fireman Z; Trost L; Kopelman Y; Segal A; Sternberg A
Isr Med Assoc J; 2000 Jan; 2(1):6-9. PubMed ID: 10892362
[TBL] [Abstract][Full Text] [Related]
11. Seroreactivity to specific antigens of Helicobacter pylori infection is associated with an increased risk of the dyspeptic gastrointestinal diseases.
Chomvarin C; Ottiwet O; Hahnvajanawong C; Intapan PM; Wongwajana S
Int J Infect Dis; 2009 Sep; 13(5):647-54. PubMed ID: 19233700
[TBL] [Abstract][Full Text] [Related]
12. Prevalence estimates of Helicobacter species infection in pancreatic and biliary tract cancers.
Osaki T; Lin Y; Sasahira N; Ueno M; Yonezawa H; Hojo F; Okuda M; Matsuyama M; Sasaki T; Kobayashi S; Tezuka S; Tanaka K; Dan N; Kuruma S; Egawa N; Kamiya S; Kikuchi S
Helicobacter; 2022 Feb; 27(1):e12866. PubMed ID: 35005807
[TBL] [Abstract][Full Text] [Related]
13. A pilot study of Helicobacter pylori infection and risk of laryngopharyngeal cancer.
Nurgalieva ZZ; Graham DY; Dahlstrom KR; Wei Q; Sturgis EM
Head Neck; 2005 Jan; 27(1):22-7. PubMed ID: 15459921
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of cagA and vacA seropositivity in asymptomatic Bangladeshi children with Helicobacter pylori infection.
Sarker SA; Nahar S; Rahman M; Bardhan PK; Nair GB; Beglinger C; Gyr N
Acta Paediatr; 2004 Nov; 93(11):1432-6. PubMed ID: 15513567
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori and the risk of benign and malignant biliary tract disease.
Bulajic M; Maisonneuve P; Schneider-Brachert W; Müller P; Reischl U; Stimec B; Lehn N; Lowenfels AB; Löhr M
Cancer; 2002 Nov; 95(9):1946-53. PubMed ID: 12404289
[TBL] [Abstract][Full Text] [Related]
16. Monitoring sentinel mice for Helicobacter hepaticus, H rodentium, and H bilis infection by use of polymerase chain reaction analysis and serologic testing.
Whary MT; Cline JH; King AE; Hewes KM; Chojnacky D; Salvarrey A; Fox JG
Comp Med; 2000 Aug; 50(4):436-43. PubMed ID: 11020164
[TBL] [Abstract][Full Text] [Related]
17. [Helicobacter pylori infection in pancreatic cancer].
Gawin A; Wex T; Ławniczak M; Malfertheiner P; Starzyńska T
Pol Merkur Lekarski; 2012 Feb; 32(188):103-7. PubMed ID: 22590913
[TBL] [Abstract][Full Text] [Related]
18. [Helicobacter pylori CagA antigen antibodies].
Havlasová J; Bures J; Rejchrt S; Voxová B; Krejsek J
Cas Lek Cesk; 1998 Jun; 137(13):404-9. PubMed ID: 9748734
[TBL] [Abstract][Full Text] [Related]
19. Combined serum IgG response to Helicobacter pylori VacA and CagA predicts gastric cancer.
Janulaityte-Günther D; Kupcinskas L; Pavilonis A; Valuckas K; Wadström T; Andersen LP
FEMS Immunol Med Microbiol; 2007 Jul; 50(2):220-5. PubMed ID: 17567283
[TBL] [Abstract][Full Text] [Related]
20. [Helicobacter pylori CagA(+) infection in gastric cancer patients].
Ławniczak M; Starzyńska T
Pol Merkur Lekarski; 2002 Sep; 13(75):216-20. PubMed ID: 12474574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
